january 8 50_conference drug interaction

Upload: duganapally

Post on 06-Apr-2018

217 views

Category:

Documents


0 download

TRANSCRIPT

  • 8/2/2019 January 8 50_Conference Drug Interaction

    1/21

    DRUG INTERACTIONS

    Guided by

    Mr.pavan

    Presented by

    G.nandiniRoll-no

    01709014

  • 8/2/2019 January 8 50_Conference Drug Interaction

    2/21

    Drug interaction

    Drug interaction can be defined as themodifications of the effects of one drug by the prior

    or concomitant of another drug

    The potential drug interactions has been

    observed to be 17% in surgical patients, 22% in

    patients in medical wards, 23% in out patients

    clinics.

  • 8/2/2019 January 8 50_Conference Drug Interaction

    3/21

    1 in 107 1 in 106 1 in 105 1 in 104 1 in 103 1 in 102

    Lightning

    Plane crash Murder

    Auto-cash

    Fatal, unexpected

    drug reaction

    Increasing risk of death

  • 8/2/2019 January 8 50_Conference Drug Interaction

    4/21

    Mechanism of drug interaction

    Pharmacokinetic interactions Absorption

    Distribution

    Biotransformation***

    Excretion

    Pharmacodynamic interactions Receptor interaction

    Receptor sensitivity

    Drug transportation

    Electrolyte balance

    Physiological interactions

    Pharmaceutical interactions

  • 8/2/2019 January 8 50_Conference Drug Interaction

    5/21

    Absorption interactions

    Where the absorption are the object drug is altered

    The net effect of such an interaction is:

    Faster or slower drug absorption

    More,or,less complete drug absorption

  • 8/2/2019 January 8 50_Conference Drug Interaction

    6/21

    The distribution pattren of the object drug is altered

    The major mechanism for distribution interaction is alteration is

    protein

    drug binding

    Distribution interaction

  • 8/2/2019 January 8 50_Conference Drug Interaction

    7/21

    Drug metabolism interaction

    Enzyme inducers :increase metabolism ofconcomitant drug therefor increase drug

    elimination and decrease drug effect

    Barbiturate, Rifampin, Phenytoin

    Enzyme inhibitors : decresae metabolism

    of concomitant drug therefor decrease drugexcretion and increase drug effect

    Cimetidine, Ketoconazole, Erythromycin

  • 8/2/2019 January 8 50_Conference Drug Interaction

    8/21

    Excretion interaction

    The excretion pattren of the object drug is altered

    Major mechanism of excretion interactions are-

    Alteration in renal flood flow

    Alteration of urine pH

  • 8/2/2019 January 8 50_Conference Drug Interaction

    9/21

    Pharmacodynamic interactions

    Receptor interaction

    Competitive

    Non-competitive Sensitivity of receptor

    Number of receptor

    Affinity of receptor

    Drug transportation

    Electrolyte balance

  • 8/2/2019 January 8 50_Conference Drug Interaction

    10/21

    Physiological interactions

    Drug A and Drug B bind to different receptors onthe same tissue but give opposite or similar

    effect

    Aspirin (anti-platelet)+Warfarin/Coumarin (anticoagulant)

    Increase bleeding

  • 8/2/2019 January 8 50_Conference Drug Interaction

    11/21

    Pharmaceutical interactions

    Chemical or physiological interactions

    Vitamin C + amphotericin B Pennicilin + Vitamin C

  • 8/2/2019 January 8 50_Conference Drug Interaction

    12/21

    Drug-Drug interaction may alter drug effect by

    Additive effect : 1 + 1 =2

    Synergistic effect : 1 +1 > 2

    Potentiation effect : 1 + 0 =2

    Antagonism : 1-1 = 0

  • 8/2/2019 January 8 50_Conference Drug Interaction

    13/21

    Drug-Food interactions

    Grape seed and cyclosporin

    Grape seed and felodipine

  • 8/2/2019 January 8 50_Conference Drug Interaction

    14/21

    Drug-Herb interactions

    Ginko biloba

  • 8/2/2019 January 8 50_Conference Drug Interaction

    15/21

    St. Johns wort: CYP3A4 inducer

  • 8/2/2019 January 8 50_Conference Drug Interaction

    16/21

    Drug features associated with potentialinteractions

    Narrow therapeutic index :

    Phenytoin

    Cyclosporine

    TheophyllineSharp response curve:

    Phenytoin

    Aminoglycoside

    VancomycinDose dependent (Michaelis-Menten) kinetic

    Phenytoin

  • 8/2/2019 January 8 50_Conference Drug Interaction

    17/21

    List of drug the most commoninteracting drug

    Antacids

    Cimetidine

    Digoxin

    Warfarin

    Theophylline

    Ketoconazole

  • 8/2/2019 January 8 50_Conference Drug Interaction

    18/21

    Problem in medical practice

    Possible reasonsPhysiological factors Pathological factors Food

    Drug interactionGenetic

    D t bl t

  • 8/2/2019 January 8 50_Conference Drug Interaction

    19/21

    i

    Drug tablet

    Drug in blood

    Drug in tissues

    Drug at receptor

    Drug metabolites Drug in urine/bil

    Desired response No response Unwanted response

    Drug interaction

    Release

    Drug in gut

    Absorption

    Distribution

    Pharmacokinetics

    Pharmacodynamics

  • 8/2/2019 January 8 50_Conference Drug Interaction

    20/21

    CONCLUSION

    TodayDrug A

    Drug B

    Drug CDrug D

    Individual physician experience

    Cost: time, money & well-being

    FuturePatient genetic

    s profiles

    Drug ADrug B

    Drug CDrug D

    Informed physician diagnosisSaving : time, money & patients life

  • 8/2/2019 January 8 50_Conference Drug Interaction

    21/21

    REFERENCES

    D.M. BRAHMANKAR

    SATHOSKAR

    The George Mateljan

    Fellers PJ, Nikdel S, Lee HS

    K, Iyer KR, Hayes RN, Sinz MW, Woolf TF, Hollenberg PF

    J. Thomas

    A. David Rodrigues

    Barrie R. Cassileth, Charles D. Lucarelli